Better Warren Buffett Stock: American Express vs. Visa

The article argues American Express may offer the better return versus Visa, citing AXP's cheaper valuation at 21.3x P/E versus Visa's 29.8x and higher expected EPS growth of 14.9% annually over the next three years versus 12.5% for Visa. It highlights American Express's premium brand, younger customer growth, and Berkshire's large AXP stake, while noting Visa's superior scalability, 47.6% average net margin, and dominant network effects. The piece is commentary rather than new company-specific news, so near-term market impact should be limited.

Analysis

AXP screens as the higher-beta beneficiary because its earnings mix is more exposed to spend growth, fee expansion, and credit normalization all at once. That creates a subtle second-order effect: in a soft-landing or no-landing environment, premium cardholders can absorb higher annual fees while younger cohorts lock in for decades, giving AXP a longer runway to reprice its franchise than a plain payments tollbooth. The market is effectively paying a lower multiple for more operating leverage, which can matter more than the headline valuation gap if consumer confidence stays intact.

V remains the cleaner quality compounder, but the market may be underestimating how much of its moat is already fully reflected in the multiple. The real risk is not immediate displacement from stablecoins; it is incremental commoditization at the margins if large issuers or wallets use alternative rails to pressure network economics over a multi-year horizon. That said, because network effects are sticky and merchant acceptance is embedded, any credible competitive threat would likely show up first as slower yield expansion rather than share loss, making the stock more vulnerable to multiple compression than to an earnings cliff.

Consensus appears to be treating this as a simple ‘buy both on weakness’ call, but the better framing is relative value plus macro sensitivity. AXP has the better upside in a benign credit environment, while V is the safer hold if growth slows and investors rotate toward durability. The key catalyst over the next 1-3 quarters is whether consumer spend and delinquency trends stay benign enough to let AXP keep compounding EPS faster than the market expects; if not, its lower multiple can re-rate lower quickly.

Key Decisions for Investors

• Long AXP vs V pair trade for 3-6 months: favor the name with greater earnings torque and lower starting multiple; stop if credit indicators or charge-offs inflect upward meaningfully.
• Buy AXP on pullbacks with a 6-12 month horizon: reward is multiple expansion plus faster EPS growth if the consumer remains healthy; key risk is fee fatigue or credit normalization.
• Hold V as a defensive compounder, but fade aggressive upside chasing above current valuation levels: upside is steadier, yet the stock is more likely to grind than rerate sharply.
• Use a short-dated hedge on AXP if macro data softens: buy put spreads into earnings or consumer-credit data releases to protect against a fast de-rating if delinquency trends worsen.